S100A2 gene is a direct transcriptional target of p53 homologues during keratinocyte differentiation

Oncogene

Volumn 25, Issue 26, 2006, Pages 3628-3637

  Lapi, E ^a   Iovino, A ^a   Fontemaggi, G ^a,b   Soliera, A R ^a   Iacovelli, S ^a   Sacchi, A ^a   Rechavi, G ^c   Givol, D ^d   Blandino, G ^a,b   Strano, S ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b Rome Oncogenomic Center   (Italy)

^c SHEBA MEDICAL CENTER   (Israel)

^d WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Differentiation; Keratinocytes; p63; p73; S100A2; Transcription

Indexed keywords

CISPLATIN; DOXORUBICIN; INVOLUCRIN; ISOPROTEIN; PROTEIN P53; PROTEIN P63; PROTEIN P73; PROTEIN S 100; PROTEIN S 100A2; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; GENE; GENE EXPRESSION REGULATION; GENE SILENCING; HUMAN; HUMAN CELL; IN VIVO STUDY; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; S100A2 GENE; TRANSACTIVATION; TRANSCRIPTION REGULATION;

CELL DIFFERENTIATION; CELLS, CULTURED; CHEMOTACTIC FACTORS; CISPLATIN; DNA DAMAGE; DNA-BINDING PROTEINS; DOXORUBICIN; GENE EXPRESSION REGULATION; GENE SILENCING; GENES, TUMOR SUPPRESSOR; HUMANS; KERATINOCYTES; NUCLEAR PROTEINS; REGULATORY SEQUENCES, NUCLEIC ACID; S100 PROTEINS; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 33646822104     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209401     Document Type: Article

References (40)

1. Attardi LD, Reczek EE, Cosmas C, Demicco EG, McCurrach ME, Lowe SW et al. (2000). Genes Dev 14: 704-718.
2. Bamberger C, Pollet D, Schmale H. (2002). J Investl Dermatol 118: 133-138.
3. Blandino G, Dobbelstein M. (2004). Cell Cycle 3: 886-894.
4. Bourdon J, Fernandes K, Murray-Kmijewski F, Liu G, Diot A, Xirodimas DP et al. (2005). Genes Dev 19: 2122-2137.
5. Brummelkamp TR, Bernards R, Agami R. (2002). Science 296: 550-553.
6. Costanzo A, Merlo P, Pediconi N, Fulco M, Sartorelli V, Cole PA et al. (2002). Mol Cell 9: 175-186.
7. Dale BA, Presland RB, Lewis SP, Underwood RA, Fleckman P. (1997). J Invest Dermatol 108: 179-187.
8. Dazard JE, Gal H, Amariglio N, Rechavi G, Domany E, Givol D. (2003). Oncogene 22: 2993-3006.
9. De Laurenzi V, Catani MV, Terrinoni A, Corazzari M, Melino G, Costanzo A et al. (1999). Cell Death Differ 6: 389-390.
10. De Laurenzi V, Costanzo A, Barcaroli D, Terrinoni A, Falco M, Annichiarico-Petruzzelli M et al. (1998). J Exp Med 188: 1763-1768.
11. De Laurenzi V, Raschellà G, Barcaroli D, Annichiarico-Petruzzelli M, Ranalli M, Catani MV et al (2000). J Biol Chem 275: 15226-15231.
12. Donato R. (2003). Microsc Res Tech 60: 540-551.
13. Eckert RL, Broome AM, Ruse M, Robinson N, Ryan D, Lee KJ. (2004). Invest Dermatol 123: 23-33.
14. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM et al. (1993). Cell 75: 817-825.
15. Fernandez-Fernandez MR, Veprintsev DB, Fersht AR. (2005). Proc Natl Acad Sci USA 102: 4735-4740.
16. Fontemaggi G, Gurtner A, Strano S, Higashi Y, Sacchi A, Piaggio G et al. (2001). Mol Cell Biol 21: 8461-8470.
17. Fontemaggi G, Kela I, Amariglio N, Rechavi G, Krishnamurthy J, Strano S et al. (2002). J Biol Chem 277: 43359-43368.
18. Gupta S, Hussain T, MacLennan GT, Fu P, Patel J, Mukhtar H. (2003). J Clin Oncol 21: 106-112.
19. Heierhorst J, Kobe B, Feil SC, Parker MW, Benian GM, Weiss KR et al. (1996). Nature 380: 636-639.
20. Hibi K, Fujitake S, Takase T, Kodera Y, Ito K, Akiyama S et al. (2003). Clin Cancer Res 9: 4282-4285.
21. Ihrie RA, Marques MR, Nguyen BT, Horner JS, Papazoglu C, Bronson RT et al. (2005). Cell 120: 843-856.
22. Jost CA, Marin MC, Kaelin Jr WG. (1997). Nature 389: 191-194.
23. Kaghad M, Bonnet H, Yang A, Creancier L, Biscan JC, Valent A et al. (1997). Cell 90: 809-819.
24. Maelandsmo GM, Florenes VA, Mellingsaeter T, Hovig E, Kerbel RS, Fodstad O. (1997). Int J Cancer 74: 464-469.
25. Mantovani F, Piazza S, Gostissa M, Strano S, Zacchi P, Mantovani R et al. (2004). Mol Cell 14: 625-636.
26. Mills AA, Zheng B, Wang XJ, Vogel H, Roop DR, Bradley A. (1999). Nature 398: 708-713.
27. Mischke D, Korge BP, Marenholz I, Volz A, Ziegler A. (1996). J Invest Dermatol 106: 989-992.
28. Pozniak CD, Radinovic S, Yang A, McKeon F, Kaplan DR, Miller FD. (2000). Science 289: 304-306.
29. Signoretti S, Waltregny D, Dilks J, Isaac B, Lin D, Garraway L et al. (2000). Am J Pathol 157: 1769-1775.
30. Steinert PM, Marekov LN. (1997). J Biol Chem 272: 2021-2030.
31. Strano S, Monti O, Pediconi N, Baccarini A, Fontemaggi G, Lapi E et al. (2005). Mol Cell 18: 447-459.
32. Strano S, Munarriz E, Rossi M, Castagnoli L, Shaul Y, Sacchi A et al. (2001). J Biol Chem 276: 15164-15173.
33. Strano S, Munarriz E, Rossi M, Cristofanelli B, Shaul Y, Castagnoli L et al. (2000). J Biol Chem 275: 29503-29512.
34. Tan M, Heizmann CW, Guan K, Schafer BW, Sun Y. (1999). FEBS Lett 445: 265-268.
35. Vellucci VF, Germino FJ, Reiss M. (1995). Gene 166: 213-220.
36. Yang A, Kaghad M, Caput D, McKeon F. (2002). Trends Genet 18: 90-95.
37. Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Dostch V et al. (1998). Mol Cell 2: 305-316.
38. Yang A, Schweitzer R, Sun D, Kaghad M, Walker N, Bronson RT et al. (1999). Nature 398: 714-718.
39. Yang A, Walker N, Bronson R, Kaghad M, Oosterwegel M, Bonnin J et al. (2000). Nature 404: 99-103.
40. Zaika AI, Kovalev S, Marchenko ND, Moll UM. (1999). Cancer Res 59: 3257-3263.